0000899243-23-016147.txt : 20230621
0000899243-23-016147.hdr.sgml : 20230621
20230621163852
ACCESSION NUMBER: 0000899243-23-016147
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230620
FILED AS OF DATE: 20230621
DATE AS OF CHANGE: 20230621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Binder Gwendolyn
CENTRAL INDEX KEY: 0001791742
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39103
FILM NUMBER: 231030415
MAIL ADDRESS:
STREET 1: C/O CABALETTA BIO, INC.
STREET 2: 2929 ARCH STREET, SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cabaletta Bio, Inc.
CENTRAL INDEX KEY: 0001759138
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 ARCH STREET
STREET 2: SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (267) 759-3100
MAIL ADDRESS:
STREET 1: 2929 ARCH STREET
STREET 2: SUITE 600
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-20
0
0001759138
Cabaletta Bio, Inc.
CABA
0001791742
Binder Gwendolyn
C/O CABALETTA BIO, INC.
2929 ARCH STREET, SUITE 600
PHILADELPHIA
PA
19104
0
1
0
0
See Remarks
1
Common Stock
2023-06-20
4
M
0
11000
1.01
A
31000
D
Common Stock
2023-06-20
4
S
0
11000
12.9932
D
20000
D
Stock Option (Right to Buy)
1.01
2023-06-20
4
M
0
11000
0.00
D
2028-10-28
Common Stock
11000
177756
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 20, 2023 adopted by the Reporting Person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.36 - $13.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option vests over four years, with 25% vested on October 11, 2019, and the remaining shares vesting in 12 equal quarterly installments thereafter.
President, Science & Technology
By: /s/ Michael Gerard, as Attorney-in-Fact
2023-06-21